Citadel Advisors
CLBT icon

Citadel Advisors’s Cellebrite CLBT Stock Holding History

Citadel Advisors’s Portfolio CLBT Stock Details CLBT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$485K Buy
35,200
+13,400
+61% +$202K ﹤0.01% 9388
2025
Q4 		$393K Sell
21,800
-60,400
-73% -$1.08M ﹤0.01% 9574
2025
Q3 		$1.52M Sell
82,200
-4,100
-5% -$64.4K ﹤0.01% 6641
2025
Q2 		$1.38M Buy
86,300
+28,300
+49% +$504K ﹤0.01% 6431
2025
Q1 		$1.13M Sell
58,000
-44,600
-43% -$939K ﹤0.01% 6701
2024
Q4 		$2.26M Buy
102,600
+12,600
+14% +$243K ﹤0.01% 5377
2024
Q3 		$1.52M Buy
90,000
+88,900
+8,082% +$1.32M ﹤0.01% 6032
2024
Q2 		$13.1K Sell
1,100
-1,700
-61% -$19K ﹤0.01% 12953
2024
Q1 		$31K Buy
+2,800
New +$28.6K ﹤0.01% 12670
2023
Q4 		– Sell
-300
Closed -$2.29K – 14344
2023
Q3 		$2.29K Buy
+300
New +$2.25K ﹤0.01% 13741
2023
Q2 		– Sell
-26,200
Closed -$160K – 14426
2023
Q1 		$160K Sell
26,200
-2,900
-10% -$15.7K ﹤0.01% 10535
2022
Q4 		$127K Buy
29,100
+4,800
+20% +$21.4K ﹤0.01% 10860
2022
Q3 		$95K Sell
24,300
-5,000
-17% -$25.1K ﹤0.01% 11134
2022
Q2 		$149K Sell
29,300
-9,200
-24% -$47.9K ﹤0.01% 10985
2022
Q1 		$246K Buy
38,500
+2,400
+7% +$15.9K ﹤0.01% 11036
2021
Q4 		$290K Sell
36,100
-68,600
-66% -$646K ﹤0.01% 10997
2021
Q3 		$970K Buy
+104,700
New +$1.09M ﹤0.01% 8236

Other funds holding CLBT

TWCM
True Wind Capital Management San Francisco, California $226M AUM 2.79% 1-Year Est. Return
VC
Voss Capital Houston, Texas $1.88B AUM 1.03% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
PP
Pertento Partners London, United Kingdom $1.37B AUM 36.36% 1-Year Est. Return
PF
Phoenix Financial Givatayim, Israel $10.5B AUM 49.21% 1-Year Est. Return
NTCM
Nine Ten Capital Management Chicago, Illinois $315M AUM 62.95% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $145B AUM 22.78% 1-Year Est. Return
CI
Clal Insurance Tel-Aviv, Israel $16.6B AUM 68.34% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

Citadel Advisors's CLBT Position: Q1 2026 in Review

Citadel Advisors increased its Cellebrite (CLBT) stake by 174% in Q1 2026, buying an estimated $13.8M and bringing the position to 1,436,201 shares worth $19.8M. The position accounts for ﹤0.01% of the portfolio, ranked #2357.

Citadel Advisors first reported a position in CLBT in Q3 2021 and has held it in 19 quarters since. 220 funds tracked by Wall St. Rank hold CLBT as of Q1 2026.

  • Citadel Advisors held 1,436,201 shares of Cellebrite worth $19.8M as of Q1 2026.
  • Citadel Advisors bought 912,442 Cellebrite shares in Q1 2026, an estimated $13.8M.
  • Cellebrite made up ﹤0.01% of Citadel Advisors's portfolio in Q1 2026, its #2357 holding.
  • Citadel Advisors first reported a position in Cellebrite in Q3 2021 and has held it in 19 quarters since.
  • 220 funds tracked by Wall St. Rank held Cellebrite as of Q1 2026.

Based on Citadel Advisors's 13F filing for Q1 2026, filed 15 May 2026.